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Al&met-The effects of epinephrine. norepinephriie, and isoproterenol on uterine 
phosphorylase were studied in intact, anesthetized rats. All three agents were found 
to increase uterine phosphorylase a activity when administered in large doses by 
intraperitoneal injection. Total phosphorylase activity was unaffected. The time course 
for the effects of epinephrine on uterine phosphorylase activity and glycogen content 
was also studied. Peak phosphorylase activation occurred within 5 min after injection, 
and the effect had disappeared within 1 hr. Increase in phosphorylase (I activity was 
accompanied by a decrease in uterine glycogen levels, which were still depressed at a 
time when phosphorylase a activity had returned to normal. 
Epinephrine was shown to stimulate phosphorylase a activity in the uteri of ovari- 
ectomized and estrogen-primed rats as well as in normal intact animals. Ovariectomized 
animals treated with estradiol had higher resting phosphorylase a activity than had 
normal untreated animals. 
The relative ability of several adrenergic blocking agents to prevent catecholamine- 
induced increases in uterine phosphorylase a activity was investigated, It was suggested 
that the catecholamines produced their effects on the uterus both directly, via Badrener- 
gic stimulation, and indirectly, via ischemia and resultant tissue anoxia induced by 
activation of a-adrenergic receptors in the uterine vasculature. 
The ability of epinephrine to activate uterine phosphorylase when administered by 
intravenous infusion was also demonstrated. 
THE activation of glycogen phosphorylase by catecholamines has been demonstrated 
in many tissues, including heart, skeletal muscle, and liver (see reviews by Ellis,l 
Stetten and Stetten,2 and Sutherland and RalP). It has also been demonstrated that 
increases in phosphorylase activity are accompanied by decreases in glycogen content 
of the tissues.8-s However, the effects of catecholamines on phosphorylase activity 
of smooth muscle have not been so well documented. Activation of phosphorylase by 
epinephrine has been reported in isolated strips of rabbit uterus7 but not in rat or 
guinea pig uterus or in rabbit intestinal strips.s*’ On the other hand, in a recent 
report Leonard and Crandall were able to show increases in phosphorylase a in 
isolated segments of rat uterus after exposure to epinephrine.8 Bueding et al. have 
failed to demonstrate activation of phosphorylase by epinephrine in isolated strips 
of guinea pig Taenia co1i.g 
The only reports concerning the efforts of epinephrine on the activity of smooth 
muscle phosphorylase in vivo are those of Leonard,lo~ll in which large doses of epine- 
phrine (500 pg/kg, i.p.) were reported to decrease both phosphorylase a and glycogen 
* This study was supported in part by a contract between the University of Michigan and the Office 
of Naval Research, NONR-1224-27. 
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content in the uteri of ovariectomized and estrogen-primed rats. The present results 
fail to support these findings with respect to phosphorylase activity after epinephrine. 
Data presented will show that, under conditions similar to those of Leonard, epine- 
phrine produces an activation of uterine phosphorylase accompanied by a decrease in 
the glycogen content of that organ. 
METHODS 
White female rats of the Holtzman strain were used throughout this investigation. 
All animals weighed from 180 to 220 g, with the exception of the ovariectomized 
estrogen-primed group, which weighed 275-300 g at the time of sacrifice. They received 
food and water ad lib. at all times. 
Commercial solutions of I-epinephrine (Adrenalin, Parke, Davis & Co), I-norepine- 
phrine (Levophed, Winthrop Laboratories) and l-isoproterenol (Isuprel, Winthrop 
Laboratories) were diluted in a solution of 0.9 % NaCl and O-1 % NaHSOs to obtain 
the proper concentration for injection. Dichloroisoproterenol (DCI) and 2- 
isopropylamino-1-(2-naphthyl)-ethanol (nethalide) were injected S.C. in doses of 10 
mg/kg and 25 mg/kg, respectively, 30 min before administration of catecholamines. 
Phenoxybenzamine (Dibenzyline, Smith, Kline & French Laboratories), in a dose of 
7 mg/kg, was injected i.p. 2 to 3 hr before catecholamine administration. Estradiol 
benzoate, dissolved in peanut oil, was administered S.C. in a dose of 50 pg/rat, 48 hr 
before epinephrine injections. 
Animals were anesthetized by the i.p. injection of hexobarbital sodium (150-180 
mg/kg) 10 min before sacrifice. The uteri were quickly cleared of adhering fat, rapidly 
excised, and frozen in isopentane cooled in a mixture of alcohol and dry ice. 
Glycogen was isolated according to the method of Hassid and Abrahami and 
glucose determined with anthrone reagent .rs Glycogen values are expressed as milli- 
grams of glycogen per gram wet weight of tissue. 
Phosphorylase was determined by a modification of the method originally described 
by Cori and Cori.14 The liberation of inorganic phosphate during the synthesis of 
glycogen from glucose-l-phosphate was used as measure of phosphorylase activity. 
Uterine samples weighing from 50 to 100 mg were homogenized (in a ground-glass 
homogenizer) in 100 volumes of a solution containing 0.05 M Tris buffer (pH 6.8). 
0.001 M EDTA, 0.02 M NaF, and O-3 % serum albumin. All procedures were carried 
out at 0”-4”. After centrifugation of the homogenate at 10,000 g for 10 min, 0*2-ml 
aliquots of the supernatant were incubated for 30 min at 37.5” in test tubes containing 
0.05 M Tris buffer (pH 6*8), 0.4% glycogen, 0.01 M glucose-l-phosphate, 0.001 M 
EDTA, 0.02 M NaF, and O-3 % serum albumin, in a final volume of 1 *O ml. Duplicate 
samples of the supernatant solutions were incubated in the same reaction mixture 
containing, in addition, AMP in a final concentration of 0.001 M. The reaction was 
terminated by the addition of 2-O ml of 10% trichloroacetic acid. The samples were 
then centrifuged in the cold room at 2,500 g for 10 min and the supernatants assayed 
for inorganic phosphate by the method of Fiske and SubbaRow.15 
The rate of liberation of inorganic phosphate was linear over the time studied and 
was proportional to enzyme concentration. When the glycogen primer was omitted 
from the reaction mixture, the liberation of inorganic phosphate was negligible. 
Also, no phosphoglucomutase activity could be detected under the conditions of this 
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assay. Phosphoglucomutase activity was determined by the method described by 
Cori, et al.ls 
The amount of inorganic phosphate liberated in the absence of AMP represented 
phosphorylase a, and the amount liberated in the presence of AMP was a measure of 
total phosphorylase. Results are reported as (phosphorylase u/total phosphorylase) 
x 100. 
RESULTS 
Uterine phosphorylase activity and glycogen content after intraperitoneal administration 
of epinephrine 
Figure 1 shows a time curve of the effects of epinephrine (500 pg/kg i.p.) on the 















. . . . 















050 Mean -ir SE 
I 1 I I I I I , 
0 5 IO 20 30 40 50 60 
TIME IN MINUTES 
FIG. 1. Effect of epinephrme (500 pg/kg i.p.) on the per cent phosphorylase a and glycogen content 
of rat uterus. In all graphs the figures in parentheses indicate the number of animals at each point. 
The phosphorylase a values at 5, 10, and 30 min after injection are significantly higher than controls 
(P < ON)1 to 0.05). The glycogen content is significantly decreased at 5,10, and 30 minutes (P CO.01). 
markedly activated 5 min after epinephrine administration and had returned to 
control levels within 1 hr after injection of the drug. Glycogen decreased progressively 
until 30 min after injection and had not returned to normal within the I-hr period 
studied. 
The total amount of phosphorylase in the uterus was not significantly altered by 
epinephrine administration. When calculated on the basis of total enzyme per 
milligram wet weight of frozen tissue, it appeared that, not only had the per cent 
phosphorylase a increased, but that total phosphorylase activity appeared to be 
greater as well. For example, 5 min after the dose of 500 pg epinephrine/kg, phos- 
phorylase a (expressed as micromoles of inorganic phosphate liberated per 30 min 
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per gram wet weight of tissue at 37.5’) had increased from 29.0 f 2.5 (mean & 
standard error of 12 controls) to 114 f 4.5 (mean f standard error of 9 treated 
animals). Total phosphorylase activity had increased from 125 f 6.5 to 194 -+ 6.6. 
However, when calculated on a per uterus basis, phosphorylase a increased from 14.6 
in the controls to 34.4 in the treated animals, while total activity actually decreased 
slightly from 62.8 to 58.5. This was due to the fact that uteri from rats injected with 
this large dose of epinephrine weighed only about 60 % as much as did control uteri, 
when frozen immediately without blotting the tissues. This in turn probably resulted 
from the decrease in vascularity and fluid content of these uteri. 
The effects of varying doses of epinephrine on uterine phosphorylase activation are 
shown in Fig. 2. In this figure the dose is plotted on a logarithmic scale against the 
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FIG. 2. Dose-response curves for the activation of uterine phosphorylase by epinephrine. Uteri were 
excised 5 min after the i.p. injection of epinephrine. The upper curve (EPI) shows the effect of 
epinephrine in normal animals; the lower curve (EPI + DBZ) illustrates the effect of epinephrine in 
animals pretreated for 2-3 hr with phenoxybenzamine (7 m&g i.p.). 
response on an arithmetic scale. Such a plot yields a linear relationship. When the 
same doses of epinephrine were administered to animals pretreated with phenoxy- 
benzamine, a much shallower dose-response curve was obtained. 
Effects of epinephrine on uterine phosphorylase activity in ovariectomized and estrogen- 
primed rats 
Since Leonard had observed only decreases in uterine phosphorylase activity after 
administration of epinephrine to ovariectomized or estrogen-primed animals, it was 
of interest to determine whether these procedures would result in a response quali- 
tatively different from that which we had obtained in normal animals. A group of 
animals was ovariectomized and after a recovery period of 2-3 weeks they were 
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injected i.p. with 500 pg epinephrine/kg and sacrificed at varying time intervals. An 
increase in phosphorylase a activity was observed, similar to that seen in normal 
animals, although of lesser magnitude (Table 1). 
A second group of ovariectomized animals received S.C. injections of 5Opg estradiol 
benzoate in peanut oil. After 48 hr they were injected i.p. with varying doses of epine- 
phrine and sacrificed 5 min later. It can be seen from the data in Table 2 that the 
TABLE 1. EFFECT OF EPINEPHRINE ON UTERINE PHOSPHORYLASE ACTIVITY IN OVARI- 
ECTOMIZED RATS 
Time after injection 
Wn) 
‘A Phosphorylase u 
N (mean f S.E.) 
Control 
5 f 
27.7 & 2.6 
43.7 & 3.8* 
:: : 
40.5 * 5.5 
34.4,31.6 
All animals received 500 pg epinephrinelkg, i.p. 
* Significantly different from controls (P < @Ol). 




Estrogen + 125 pg epi./kg 
Estrogen + 250 pg epi./kg 
Estrogen + 500 pg epi./kg 
‘A Phosphorylase CI 
N (mean f S.E.) 
:: 
33.7 f. 1-8 
39.6 + 3.7 
51.5 & 1.8* 
2 47.7 f 1.7* 
All animals sacrificed 5 mins after epinephrine injections. 
* Significantly different from estrogen alone (P < OGOl). 
per cent phosphorylase a levels are almost identical with those seen after similar doses 
of epinephrine in normal animals, with the exception of the dose of 500 pg/kg, which 
produced less activation in the estrogen-primed animals than in the normals. It is also 
apparent that the administration of estradiol itself raised the levels of phosphorylase a 
above the levels previously noted for untreated ovariectomized animals, although the 
increase was not statistically significant. Furthermore, per cent phosphorylase a levels 
in ovariectomized estrogen-primed rats were significantly higher (Pt0.01) than the 
levels in any of the groups of normal untreated animals (which averaged from 20.0 & 
l-2 to 23.1 f 1.7). 
Within 48 hr after the administration of estradiol to ovariectomized animals, the 
uterine weights had increased markedly. The increases in size and weight were ac- 
companied by hyperemia, hydration, and softness of the tissue and by corresponding 
increases in the total phosphorylase activity per uterus. 
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The influence of adrenergic blockade on catecholamine-induced activation qf uterine 
phosphorylase 
Figure 3 illustrates the effects of several adrenergic blocking agents on the phos- 
phorylase activation induced by two different doses of epinephrine. Normal animals 
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FIG. 3. Effect of adrenergic blocking agents on uterine phosphorylase activation by epinephrine 
(EPI). Uteri were excised 5 min after the injection of epinephrine. Nethalide (NETH, 25 mg/kg) 
and DC1 (10 mg/kg) were injected S.C. 30 min before epinephrine administration. Phenoxybenzamine 
(DBZ) was administered i.p. in a dose of 7 mg/kg, 2-3 hr prior to epinephrine injections. 
Pretreatment of animals with phenoxybenzamine (7 mg/kg i.p., 2-3 hr before 
epinephrine injections) partially blocked the epinephrine-induced activation of uterine 
phosphorylase, whereas DC1 (10 mg/kg s.c., 30 min before epinephrine) or nethalide 
(25 mg/kg similarly injected) produced no significant blockade of the response. Pre- 
treatment with both phenoxybenzamine and nethalide resulted in a response to 
epinephrine significantly lower than that seen after pretreatment with phenoxybenza- 
mine alone (P < 0.02). Neither phenoxybenzamine nor nethalide alone altered 
phosphorylase a levels in control animals. 
The i.p. administration of norepinephrine (250 pg/kg) or isoproterenol (100 pg/kg) 
produced significant activation of uterine phosphorylase (P < 0.001). This is shown 
in Fig. 4. Prior administration of phenoxybenzamine completely blocked the response 
to norepinephrine but did not alter the response seen after isoproterenol. On the 
other hand, the response to isoproterenol was significantly decreased (P < O-01) by 
pretreatment with nethalide, a procedure which did not alter the response to nore- 
pinephrine. 
E.ect of stagnant anoxia on uterine phosphorylase activity 
A marked constriction of the uterine vasculature was observed in animals which 
had received intraperitoneal injections of epinephrine or norepinephrine. This 
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vascoconstriction was abolished by pretreating the animals with phenoxybenzamine. 
Since pretreatment with phenoxybenzamine also markedly decreased the phosphory- 
lase activation seen after these drugs, it was conceivable that the vascoconstriction 
and subsequent tissue anoxia were contributing to the observed increases in phos- 
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FIG. 4. Effect of adrenergic blocking agents on uterine phosphorylase activation by norepinephrine 
(NB) and isoproterenol (Isuprel, ISUP). Uteri were excised 5 min after catecholamine injections. 
Nethalide (NETH) and phenoxybenzamine (DBZ) were administered as in Fig. 3. 
uterine blood vessels at both ends of one uterine horn were ligated for 5 min and a 
segment of that horn removed and assayed for phosphorylase. The opposite horn 
of the same uterus was similarly manipulated, but the vessels were not ligated, and a 
portion of this horn was removed for estimation of control phosphorylase activity. 
The data in Table 3 show that phosphorylase a activity could be markedly increased 
by ligation of the uterine blood vessels for 5 min. 
TABLE 3. EFFECT OF LIGATION OF UTERINE VESSELS ON UTERINE PHOSPHORYLASE ACTIVITY 
Treatment 
Control 
Uterine vessels ligated for 5 min 
‘4 Phosphorylase a 
N (mean f S.E.) 
9 24.4 & 1.6 
8 441 f 2.5* 
* Significantly different from controls (P < OGOl). 
Effect of intravenous infusion of epinephrine on uterine phosphorylase activity 
It was of interest to determine whether epinephrine was capable of activating 
uterine phosphorylase when administered by other than the intraperitoneal route. 
Leonard has reported that epinephrine does not affect uterine phosphorylase activity 
when administered subcutaneously, even in large doses.isJ7J* Similarly, Hombrook 
and Brody have noted that subcutaneous injections of epinephrine do not activate 
cardiac muscle phosphorylase unless the animals are pretreated with phenoxybenza- 
mine.5 Apparently, intense vascoconstriction at the site of injection prevents rapid 
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uptake of the drug by the systemic circulation. Therefore, a number of animals 
received varying doses of epinephrine by intravenous infusion into an external jugular 
vein, as previously described.5 The results are shown in Table 4. It is apparent that 
uterine phosphorylase can be activated by intravenous infusion of epinephrine, 
although the maximal activation attained is considerably less than that seen after 
intraperitoneal injections of the drug. Increasing the rate of infusion beyond 2-O pg/ 
kg/mm produced no further activation of phosphorylase. 
TABLE 4. EFFECT OF INTRAVENOUS INFLTSION OF EPINEPHRINE ON UTERINE PHOSPHORY- 
LASE ACTIVITY 
Treatment 
‘A Phosphorylase a 
N (mean & SE.) 
Saline infusion 
Epj., 1.0 rglkglmjn 
Ep!., 2.0 rgkg’mm 4 PgLglkglmin 
Epl., 8.0 pg/kgmin 
: 
18.0 f 3-2 
t 
4 
Animals were infused for 5 min at the rates indicated in the table. 
* Significantly different from controls (P < 0 01). 
t Significantly different from controls (P < 0 001). 
DISCUSSION 
The changes observed in uterine phosphorylase activity and glycogen levels after 
epinephrine administration are similar to those previously observed in this laboratory 
for heart and skeletal muscle.5 The phosphorylase data are not in agreement with 
those reported by Leonard, who observed only decreases in uterine phosphorylase 
activity after administration of identical doses of epinephrine.rsJr It is difficult to 
compare many of our results with those cited above, since no experiments were 
reported on untreated control or ovariectomized animals at times less than I hr after 
epinephrine administration. However, decreases in uterine phosphorylase a activity 
were reported 5 min after administration of epinephrine to estrogen-primed animals. 
In our experiments, at this time after drug administration, phosphorylase a levels are 
markedly elevated. We are at present unable to explain the discrepancies between 
our results and those previously described above. In a more recent report, significant 
activation of phosphorylase a has been demonstrated in isolated uterine segments 
exposed to epinephrine for 2 min. 8 Therefore, although the results of our in vivo 
experiments do not concur with those of Leonard, they do tend to support the recent 
in v&o findings from that laboratory. Earlier studies in the literature have indicated 
that epinephrine does not activate phosphorylase in the isolated rat uterus3 but no 
experimental data were included with these reports. 
The decreases observed in the glycogen content of the uterus after intraperitoneal 
injections of epinephrine are similar to those previously described,laJi although they 
appear to be of somewhat shorter duration. The maximal decreases reported above 
occurred 1 hr after administration of epinephrine, whereas in our experiments maximal 
decreases were seen 30 min after injection and had begun to return toward normal 
within 1 hr. No glycogen determinations were carried out by us at times greater than 
1 hr after epinephrine administration, and further comparison is not possible. 
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Simultaneous increases in phosphorylase activity and glycogen content of rat 
uterus after injections of estradiol have been demonstrated by LeonardlOJl and by 
Bo, who used histochemical techniques. 1s The ability of estrogen treatment to elevate 
uterine glycogen levels had been previously reported. lsJ%ai The present results tend 
to support these earlier observations with respect to the increased phosphorylase c1 
levels after estrogen. Not only was per cent phosphorylase a elevated, but total 
phosphorylase activity per uterus also increased. It seems likely that the gradual, 
sustained increase in phosphorylase a activity seen after estrogen treatment is different 
in nature from the more marked, acute activation produced by epinephrine admini- 
stration. The former is accompanied not only by increases in glycogen but by general 
proliferative changes in the uterus, including increases in weight, hydration, total 
phosphorylase activity, and activity of other enzymes as we11.22 The observation that 
glycogen levels increase in the face of increased phosphorylase activity after estrogen 
seems contradictory if we accept the hypothesis that phosphorylase activation pro- 
motes glycogenolysis in vivo. A possible explanation may lie in the observation by 
Gorski and Mueller that estradiol administration in rats produces substantial in- 
creases in uterine content of UTP, UDPG, and UDPAG.23 The UDPG-transglycolase 
pathway has been suggested as being the normal pathway for glycogen synthesis 
in vivo, and it is conceivable that estrogen-induced activation of this pathway might 
result in increased glycogen deposition in the uterus in spite of moderate increases in 
phosphorylase activity. Bo has suggested teleologically that the enzyme activity in the 
uterus may be elevated after estrogen stimulation in order to break down the poly- 
saccharide.19 
Rudzik and Miller have demonstrated that the concentration of epinephrine in 
the rat uterus during estrus is twice that found during diestrus.24 This was later con- 
firmed by Wurtman et al., who further reported that the uptake and retention of 
exogenous epinephrine by rat uterus was greater during estrus than during diestrus.25 
These findings may be related not only to the increased levels of phosphorylase a 
seen after estradiol administration but also to the decreased sensitivity of uterine 
phosphorylase to exogenous epinephrine, which has been observed in ovariectomized 
rats.8 
The classification of the uterine phosphorylase response to catecholamines as 
either an a- or /3- or perhaps as both an CL- and /3-adrenergic receptor is somewhat 
difficult on the basis of in vivo studies.7 The ability of norepinephrine to stimulate 
phosphorylase activity is an indication that a-adrenergic receptors are involved, since 
norepinephrine is considered to be primarily a-adrenergic in action. This is further 
substantiated by the observation that this response is completely abolished by the 
a-adrenergic blocking agent, phenoxybenzamine, but is not affected by the @blocking 
agent, nethalide. However, it is apparent that a-adrenergic receptors are also involved, 
as indicated by the ability of isoproterenol to stimulate uterine phosphorylase a 
activity and the blockade of this effect by nethalide, but not by phenoxybenzamine. 
Furthermore, the effects of epinephrine, which is assumed to possess both Q- and B- 
adrenergic activity, were more completely blocked by pretreatment with both phenoxy- 
benzamine and nethalide than by pretreatment with either agent alone. These observa- 
tions indicate that activation of uterine phosphorylase may be accomplished by 
t The terms a- and /3-receptor are used in the connotation originally proposed by Ahlquist (Amer. 
J. Physiol. 153, 586, 1948). 
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stimulation of either a- or ,f3-receptors. However, there is some indication that the 
a effect is an indirect one, resulting from stimulation of a-receptors in the blood 
vessels supplying the uterus, rather than upon the uterine smooth muscle itself. The 
route of catecholamine administration used in the above experiments allows high 
concentrations of the drugs to accumulate at these sites, and the resulting intense 
vascoconstriction, which can be observed grossly, may produce sufficient tissue 
anoxia to activate uterine phosphorylase. This concept is supported by the observa- 
tion that ligation of the uterine vessels for 5 min resulted in a marked activation of 
phosphorylase in the anoxic segment of the uterus. It should be noted that the C( 
components of the responses to 250 pg and 500 pg epinephrine/kg (i.e. those portions 
of the responses blocked by phenoxybenzamine), as well as the response to 250 pg 
norepinephrinelkg, are of the same magnitude as the increases produced by ligation 
of the uterine blood vessels. These results are not in agreement with those of Leonard,11 
who reported slight decreases in phosphorylase a in the uteri of estrogen-primed rats 
after ligation of the uterine vessels for 10 min. However, they are consistent with the 
findings of Parmeggiani and Morgan,26 who observed substantial increases in per 
cent phosphorylase a in isolated hearts exposed to anoxia for 2 min. 
The significance of the effects of catecholamines on phosphorylase activity in the 
uterus, with respect to their actions on uterine motility and tone, remains to be 
determined. 
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